Shares of AstraZeneca PLC AZN inched down 0.57% to £115.88 Monday, on what proved to be an all-around grim trading session ...

FDA has approved Tagrisso for the treatment of adult patients with locally advanced, unresectable NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based ...

Research shows that between 2018 and 2022, industry-sponsored trials enrolled over eight times more patients than federally ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

Roche (OTCQX:RHHBY) said Monday that three obesity and diabetes drug candidates acquired through its takeover of Carmot ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

BridgeBio Pharma has been on the road to redemption ever since its treatment for a rare and fatal heart condition, acoramidis ...

More than four years ago, former President Donald Trump’s administration accelerated the development and rollout of the covid ...

The lawyer representing a family currently locked in a legal battle with the NHS over a bid to sedate a Down’s syndrome man ...

Brigham researchers have developed a nasal spray called PCANS that blocks a wide range of respiratory infections by trapping ...

Then, in mid-September, after receiving an offer for its shares from a moneyed group of institutional investors, Summit sold ...

Installation reports from the Amsterdam RAI, where broadcast and AV swapped business cards in a way never seen before, as AI ...